Advertisement

Picture Berlin Partner Voices from Berlin-Brandenburg Georg Duda 650x200px
Organisation › Details

Temedica GmbH

Temedica is a Munich, Germany-based digital health company with a mission to bring the patient into the center of healthcare. The company develops state-of-the-art digital patient companions for complex, chronic conditions. These apps support patients with personalized guidance and help them navigate through healthcare systems by considering their individual needs. Through direct and long-term interaction with patients, Temedica generates unique and previously unknown real-world evidence about disease progression and the individual effectiveness of therapies. Temedica has an expertise in the personalized support of patients as well as in compiling, structuring and analyzing respective health data. Its data analytics platform Permea is designed to enable unique insights along the entire healthcare value chain and patient journey. Temedica is supported by a consortium of renowned investors with longstanding track-records in the biopharmaceutical industry, including the founding investors of BioNTech. *

 

Period Start 2017-12-06 renamed
  Predecessor Physovia GmbH
Products Industry digital health (healthcare informatics)
  Industry 2 digital therapeutic (dTx)
Persons Person Seibert, Gloria S. (Temedica 202001 Managing Director + Co-Founder)
  Person 2 Friedrich, Benjamin (Temedica 202201 CMO)
     
Region Region München (Munich)
  Country Germany
  Street 27 Paul-Heyse-Str.
  City 80336 München
  Tel +49-89-215544970
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: Temedica GmbH. (1/12/22). "Press Release: Temedica Introduces Permea. First Analytics Platform Integrating Patient-Generated Health Data". Munich.
     
   
Record changed: 2022-03-16

Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x200px

More documents for Temedica GmbH


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Voices from Berlin-Brandenburg Georg Duda 650x200px




» top